The SCIMICKD study

• Research type

  Research Study

• Full title

  Systematic Characterization of Immune Mediated Inflammatory and Chronic Kidney Disease (SCIMICKD)

• IRAS ID

  356146

• Contact name

  Eoin McKinney

• Contact email

  efm30@cam.ac.uk

• Sponsor organisation

  Cambridge University Hospitals NHS Foundation Trust and University of Cambridge

• Duration of Study in the UK

  5 years, 0 months, 1 days

• Research summary

  Observational study in immune-mediated inflammatory and chronic kidney diseases aiming to explore disease classification and mechanism through molecular phenotyping, exploring the underlying cellular mechanisms.
  Aims:
  a) Molecular phenotyping of patients and samples from patients with chronic kidney disease (CKD) and/or immune-mediated inflammatory disease (IMID).

  b) To investigate differences in genomic traits from people with immune mediated and inflammatory disease and ‘healthy’ individuals. We wish to (a) characterize differences present and (b) infer how those changes contribute to susceptibility, activity or progression of each, their response to or adverse effects from administered treatment.
  

• REC name

  North East - Newcastle & North Tyneside 1 Research Ethics Committee

• REC reference

  25/NE/0131

• Date of REC Opinion

  16 Jul 2025

• REC opinion

  Favourable Opinion